8/14/2019 7:01:23 AM
Regeneron Announces Positive Topline Results From Phase 3 Trial Of Evinacumab
8/13/2019 7:02:30 AM
Regeneron Pharma: FDA Approves EYLEA Injection Prefilled Syringe
8/12/2019 10:03:16 AM
PALM Ebola Trial Stopped Early As Regeneron's REGN-EB3 Therapy Shows Superiority To ZMapp In Preventing Ebola Deaths
8/6/2019 6:31:38 AM
Regeneron Q2 Revenues Increase 20% To $1.93 Bln
8/6/2019 2:17:41 AM
Meggitt: Philip Green, Executive Director, Commercial & Corporate Affairs, To Retire From Board At The End Of Dec
6/28/2019 7:01:29 AM
Regeneron, Sanofi: CHMP Recommends Approval Of Dupixent For Moderate-to-Severe Atopic Dermatitis In Adolescents
6/21/2019 1:00:40 AM
Regeneron, Sanofi: Phase 2 Proof-of-concept Trial Evaluating IL-33 Antibody REGN3500 Met Primary Endpoint
6/14/2019 7:02:16 AM
Regeneron Announces Positive Early-stage Data For REGN1979 In Patients With R/R B-cell Non-Hodgkin Lymphoma